Dyax

Dyax discovers, develops and commercializes treatments for hereditary angioedema and other rare diseases.

Business Model:

Revenue: $97.5M

Employees: 51-200

Rankings

Detailed Dyax Information

Dyax was acquired by Shire.
The acquisition happend on 2015-11-02.
Details of the transaction were not public

Acquirer

Geographic Data

Dyax headquarters map

Address: 55 Network Dr

City: Burlington

State: MA

Zip: 01803

Country: US

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$60M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Dyax discovers, develops and commercializes treatments for hereditary angioedema and other rare diseases.

Contact Phone:
+16172252500

Contact Email:

Dyax went public on 8/25/2000 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
8/25/2000

IPO Valuation:
$271M

Ticker Symbol:
DYAX

IPO Price:
$15/share

Amount Raised:
$216M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
8/2000 IPO $60M
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research